Aggressive Natalizumab Treatment For Jc Virus-Negative Relapsing-Remitting Multiple Sclerosis? Cost-Effectiveness Of First-Line Versus Second-Line Natalizumab Treatment
May 1, 2014, 00:00
10.1016/j.jval.2014.03.350
https://www.valueinhealthjournal.com/article/S1098-3015(14)00401-X/fulltext
Title :
Aggressive Natalizumab Treatment For Jc Virus-Negative Relapsing-Remitting Multiple Sclerosis? Cost-Effectiveness Of First-Line Versus Second-Line Natalizumab Treatment
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00401-X&doi=10.1016/j.jval.2014.03.350
First page :
A59
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
1387